Patent · US Active

Compositions and methods for vaccinating against HSV-2

US9205146B2 · kind B2 · utility

0Cited by
2References
8Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 12, 2014
Grant dateDec 8, 2015
Priority date
Expiry dateSep 12, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/16634
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.